Objective: To develop a multivariable logistic risk model for predicting early mortality following aortic valve replacement (AVR) in adults, and to compare its performance against existing AVR-dedicated models. Methods: Prospectively collected data from the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) database project were used. Thirty-five preoperative variables from AVR literature were considered for analysis by chi-square method and multiple logistic regression. Using the bootstrap re-sampling technique for variable selection, five plausible models were identified. Based on models' calibration, discrimination and predictive capacity during n-fold validation, a final model, the AVRScore, was chosen. An additive score, derived from the final model, was also validated externally in a consecutive cohort. The performance of AVR-dedicated risk models from the North West Quality Improvement Program (NWQIP) and the Northern New England Cardiovascular Study (NNE) groups were also assessed using the receiver operating characteristic (ROC) curve and the Hosmer-Lemeshow (H-L) chi-square test. 73 (0.62, 0.84) and an H-L p-value of 0.48 ( p > 0.05). The NWQIP and NNE risk models achieved acceptable discrimination of ROC of 0.77 (0.73, 0.81). However, both models obtained H-L p-values of 0.002 ( p < 0.05), indicating a poor fit in our cohort. Conclusion: Existing AVR-dedicated risk models were deemed inappropriate for risk prediction in the Australian population. A preoperative risk model was developed using prospective data from a contemporary AVR cohort. #
Introduction
Aortic valve replacement (AVR) has seen considerable growth in the past 50 years and still remains the gold standard treatment for degenerative aortic valve diseases [1] . It is estimated that more than 200 000 AVR procedures are performed annually worldwide [2] . On average, the expected in-hospital mortality rate for patients undergoing isolated AVR procedures is 2.8%, and for those undergoing simultaneous coronary artery bypass grafting (CABG), it is 5.3% [3] .
Although post-AVR mortality rates have reduced over the years, the age and overall risk profile of patients has increased [2] . It is estimated that severe aortic lesions are prevalent in approximately 4.5% of individuals above the age of 75 years [4] . According to recent reports, nearly 32% patients with severe aortic stenosis (AS) are not referred to surgery [5] . Morton and Nga [6] have confirmed similar trends in Australian patients. Most common reasons for nonoperative management included old age, severe co-morbidities and patient refusal [7] . Whilst conventional surgical AVR can be achieved with an early mortality of 1-2% in low-risk patients, the risks of complications increase in elderly patients with severe co-morbidities. Trans-catheter aortic valve implantation (TAVI) techniques currently under trial may present an alternative lower-risk, less invasive approach for treatment of AS in high-risk surgical patients. Early reports have shown acceptable morbidity and mortality (30-day) outcomes following TAVI [8] .
Accurate AVR risk models enable the comparison of results between institutions and surgeons by adjusting for differing case-mix. They are also useful in the areas of clinical decision making, preoperative patient education and consent and in the selection of patients for TAVI [9] . Currently, high-risk patients, defined as having a European System for Cardiac Operative Risk Evaluation (logistic EuroSCORE) [10] between 9.2% and 19.9% (median = 11%), are being considered for TAVI in Europe [9] . However, Parolari and colleagues [11] have recently provided evidence of poor performance of both additive and logistic EuroSCORE in valve cohorts, strongly recommending the use of alternative risk algorithms in valve surgery. Whilst several valve-and AVR-specific risk prediction models have been developed internationally [12] [13] [14] , few used robust methods for both variable selection and model validation. We aim to validate two recent risk models developed by the North West Quality Improvement Program (NWQIP) [12] and the Northern New England Cardiovascular Study (NNE) Group [13] . We hypothesise that an AVR risk prediction model derived locally would outperform existing AVR-specific risk scores.
Methods

The database
The Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) database is a large, multicentre registry that was formed in 2001. The main goal of the project was to develop a standardised data-definition set that could be used throughout Australian cardiac surgical units for purposes of generating performance indicators and establishing national standards for benchmarking surgical performance [15, 16] . Currently, the registry has over 22 centres participating, with a capture of 80% of public hospitals performing cardiac surgery in Australia. The institutional review board of each participating hospital had approved the use of these databases for research; hence, the need for individual patient consent was waived for this study. The minimum ASCTS data set comprises 287 variables. ASCTS data collection and audit methods have been previously published in detail [17, 18] . A 30-day follow-up is performed for all patients to obtain re-admission and mortality data. Mortality information is further validated through linkage to national death index (NDI) data. 
Patient population
Statistical methods
Model development
All data were collected in a customised database, deidentified and exported for data analysis. Stata version 10.1 was used for data cleaning and statistical analysis. Thirty-five preoperative risk factors were considered for analysis. The decisions for inclusion of candidate variables were based on existing literature and recommendations by a clinician.
The individual association between each candidate variable and mortality was tested using chi-square analysis. All variables with a p-value less than 0.10 from chi-square analysis were considered for entry into multivariable analysis. Bootstrap multiple logistic regression was used for model development [13, 16, 19] . The proportion of times a variable was identified as a significant predictor in 1000 repeated bootstrap samples was recorded [16] . Five plausible multiple logistic regression models were developed from variables that were significant in at least 80%, 70%, 60% and 50% of the bootstrap samples. One model comprising all variables was developed for comparison of results. The firstdegree interaction effect between clinically relevant risk factors and multicollinearity for all possible pairs of risk factors was also investigated. Based on models' Akaike Information Criterion (AIC) estimate [20] , prediction mean square error (MSE) (indicators of distance between prediction and truth) and performance during validation, a final optimal multiple logistic model (AVR-Score) was chosen [16] .
A simplified additive score system was also developed by transforming the b-coefficients corresponding to each predictor in the AVR-Score. Additive scores were obtained by dividing b-coefficients by the absolute value of the smallest existing b-coefficient and rounding off to the nearest whole number. To calculate an individual's total risk, additive scores relevant to his/her preoperative profile were summed up to obtain a 'total additive score'. In a conversion table, the average expected mortality rate corresponding to the range of total additive scores obtained from the cohort (n = 3544) were tabulated.
Model validation
All five candidate models were subjected to n-fold internal validation using the bootstrap re-sampling technique [12, 16] . Based on 100 random samples created with replacement of 70% of data, the average area under the receiver operating characteristic (ROC) curve and the average Hosmer-Lemeshow (H-L) goodness-of-fit p-value [21] were estimated: the former, to assess the (average) percentage of times the models will predict a higher probability of mortality for observed cases (non-survivors) than observed non-cases (survivors) (i.e., discrimination capacity) and the latter, to assess the models' overall fit in the cohort (i.e., calibration capacity). Furthermore, the AVRScore was validated internally in the single sample (n = 3544) to compare performance with other existing international models that only underwent single-sample validation. To further ascertain the generalisability of our final model, the AVR-Score was externally validated on 1258 consecutive AVR procedures performed between 1 July 2008 and 30 June 2009.
To benchmark AVR-Score's performance against existing AVR-dedicated risk scores, two concurrent risk models developed by NWQIP and NNE groups were chosen and validated using ROC and H-L goodness-of-fit test. To obtain a fair evaluation of model performance, our data set inclusion criteria and the outcome variable of interest were adjusted in concordance with models' original inclusion criteria and end point.
Missing values
The highest number of missing values incurred in the following variables: unstable angina (1.2%); New York Heart Association (NYHA) class (2.8%) and ejection fraction estimate (3.0%). Any patient with one or more missing observations was excluded from the analysis. In the final model chosen (AVR-Score), 226 patients were excluded due to missing values.
Results
Our cohort comprised of 3544 AVR procedures collected by the ASCTS database between June 2001 and June 2008, where 3.6% (126) of procedures were redo valve operations. The majority of the patients were male (62.2%). One in five patients was over 80 years of age, and as a group, octogenarians observed the highest mortality rate (7.0%). Majority of procedures in the study cohort comprised of isolated AVR (47.6%) and AVR and CABG (45.7%), observing mortality rates of 3.3% and 4.8%, respectively.
Out of 35 preoperative variables, 27 were identified as potential predictors of mortality from chi-square analysis, and were therefore considered for entry into bootstrap variable selection method. Patient's sex ( p = 0.671) was forced into multivariable analysis, despite its lack of significance. Table 1 summarises the results obtained from the 1000 random, repeated samples generated during bootstrap variable selection. No preoperative variable (of 27 variables) was found significant in all (100%) bootstrap samples. Three variables (age, renal dysfunction and left main disease) were selected as significant predictors of early mortality, in at least 80% of the samples. A further three variables (NYHA class, infective endocarditis and previous cardiothoracic surgery) were significant in at least 70% of the samples. Two additional variables (ejection fraction and cerebrovascular disease) were selected as determinants of early mortality in at least 60% of the samples. A further two variables (arrhythmia and peripheral vascular disease) were found to be significant in at least 50% of the samples. The remaining 17 variables appeared in less than 50% of the bootstrap samples, and were therefore labelled as 'noise' variables.
Using multiple logistic regression, we developed four models with variables selected at least 80% of the time (Model 1), 70% of the time (Model 2), 60% of the time (Model 3) and 50% of the time (Model 4) by bootstrap method. Furthermore, a 'control' model comprising all potential variables was also developed for comparison of results (Model 5). The AIC estimates and prediction MSE, obtained by each of the plausible models, during model creation, are shown in Table  2 , whilst their average ROC, average H-L p-value (from n-fold validation) and ROC and H-L p-value (from single-sample validation) are summarised in Table 3 .
Results from n-fold validation demonstrate that all models had acceptable calibration capacity, achieving H-L p-value greater than 0.05 (Table 3) . When comparing overall model performance (AIC, MSE, average H-L p-value and average ROC), it was apparent that Model 4 achieved the best average predictive and discrimination capacity (AIC: 1027; MSE: 0.036; average H-L p-value: 0.12; and average ROC: 0.78) ( Table 3) . Nevertheless, Model 4 achieved a significant H-L pvalue ( p < 0.05) during single-sample validation, indicating a poor fit in our population. Subsequently, Model 3, the model with the next best AIC, MSE, average H-L p-value and ROC combination (1032.16, 0.037, 0.41 and 0.78, respectively) was chosen as our final model for risk prediction, the 'AVRScore' (Fig. 1) . The model comprised eight predictors (age, NYHA class, left main disease, infective endocarditis, cerebrovascular disease, renal dysfunction, previous cardiac surgery and estimated ejection fraction), which were found significant in at least 60% of bootstrap samples ( Table 1 ). The AVR-Score correctly classified 59.4% of observed cases (nonsurvivors) and 79.4% of observed non-cases (survivors) within our cohort. Overall, the model correctly classified early mortality outcome of 79.6% of patients. Using the estimated b-coefficients of the final model, displayed in Table 4 , the risk of early mortality was predicted for all patients as shown in example 1. The AVR-Score predicted an overall mortality rate of 4.16% (95% confidence interval (CI): 3.48%, 4.84%) in the study population, a very accurate approximation of the actual mortality observed (4.15%). The model was also used to predict risk of early mortality in several key subgroups of patients with good results.
1 Furthermore, Table 4 highlights a simple additive risk score system derived from the b-coefficients. According to the additive score conversion table (Table 5) , a male patient presenting with the following risk profile: 75 years old (additive score = 5), severe renal dysfunction (additive score = 8), NYHA class III (additive score = 1), moderately impaired left-ventricular function (additive score = 2) and left main disease (additive score = 3), has a corresponding total additive score of 19, indicating an estimated early mortality risk of 25%. During its external validation in a consecutive cohort, the additive score achieved an ROC of 0.73 (Fig. 2) and an H-L p-value of 0.478 ( p > 0.05), indicating fair performance in the local cohort.
The performance of the AVR-Score score was further benchmarked against existing AVR-dedicated risk models in Table 6 . The models from the NWQIP and NNE groups, which examined patients' in-hospital mortality risk (only) were validated in a cohort restricted to 3306 (AVR AE CABG) procedures collected by the ASCTS database (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) ). Both models, upon validation, achieved acceptable discrimination (ROC: 0.77); but obtained p-values less than 0.05 in the H-L goodness-of-fit test ( p = 0.002), suggesting poor calibration. When the observed overall in-hospital mortality (3.63%) was compared with that predicted by each model, the NNE model showed greater accuracy in its prediction (3.92%) than the NWQIP model (6.92%).
Discussion
This is the first study to investigate the preoperative risk factors associated with early mortality in a cohort of patients undergoing AVR in Australia. Due to salient data collection and audit mechanisms employed by the ASCTS database [17, 18] , we experienced minimal erroneous data and very few variables with missing values. Using the bootstrap method of variable selection, eight preoperative risk factors were found to be truly independent predictors of early mortality in Australian patients. Results from internal and external validation suggest that the AVR-Score had acceptable discrimination (ROC = 0.78 and 0.73, respectively) and calibration capacity (H-L p-value <0.05) amongst Australian patients undergoing AVR.
Most predictors identified by bootstrap variable selection were consistent with the existing AVR literature. Nevertheless, preoperative factors relating to operation status (e.g., emergency or urgent status) and complexity of operation (e.g., concomitant CABG or MVP) appeared less significant in our cohort. In particular, these variables appeared significant in less than 50% of the random bootstrap samples generated during variable selection (Table 1) . It is [ ( ) T D $ F I G ] likely that such variables dropped out during bootstrap variable selection as a consequence of low numbers of patients undergoing emergency (1.7%) or highly complex procedures (6.7%). Further, it is possible that a slight increase in procedural complexity is no longer a determinant of poor early outcomes. Tjang and colleagues [22] also found little grounds for 'concomitant CABG' as a predictor of post-AVR CI: confidence interval; CABG: coronary artery bypass graft; CVA: cerebrovascular accident; EF: ejection fraction; GFR: glomerular filtration rate, in millilitres per minute; NYHA: New York Heart Association; RIND: reversible ischaemic neurological deficit; and TIA: transient ischaemic attacks. Example 1: Calculating predicted risk using patient data and logistic regression coefficients. Probability of mortality = e A /(1 + e A ), where, A = P Xb, b = beta coefficient X = risk factor. For a male AVR patient who is 75 years old and has the following four preoperative risk factors: NYHA = NYHA class III, GFR = 25, EF = 40%, left main disease, and no prior history of cardiothoracic surgery, the risk of early mortality is: mortality, further implying that such procedures may no longer pose extra risk in patients undergoing AVR in contemporary populations. The benefit of using bootstrap aggregating 'bagging' technique in cardiac risk models has been highlighted in several recent studies [16, 23] . The methodological approaches for 'bagging' ensured the selection of highly robust variables into our final model, whilst ascertaining reliable results in model validation. Our AVR-Score comprised predictors that were concordant with those found in recent AVR-dedicated risk models developed by the NWQIP [12] and the NNE [13] cohorts. Both models employed bootstrap methods at either variable selection or model validation stages of model development. The AVR-Score, on the other hand, was strengthened by use of bootstrap-repeated sampling at both variable selection and model validation stages.
According to our results, the AVR-dedicated models by the NWQIP and NNE groups fitted poorly in our cohort (H-L pvalue <0.05). The NNE model, in particular, was based on an 'earlier' (1991-2003) multicentre cohort of 5793 AVR AE CABG patients, which may have affected its capacity to calibrate well in our contemporary population. In addition, upon further comparison of the two cohorts, it was apparent that the NNE group had higher proportions of urgent surgeries (41.4% vs 21.9%), history of chronic heart failure (51.7% vs 26.1%) and patients with a high NYHA classification (NYHA III: 51.3% vs 39.9% and NYHA IV: 17.7% vs 9.4%) compared with the ASCTS cohort. The original NWQIP cohort by contrast was fairly recent (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) and comprised 4550 AVR AE CABG patients, who also displayed baseline characteristics similar to the ASCTS cohort. Nevertheless, the NNE model yielded a more accurate estimate of overall risk of in-hospital mortality than the NWQIP model (Table 6 ).
In contrast to examining patients' in-hospital-mortality status only, we analysed a composite of in-hospital and 30-day mortality outcomes following AVR. This, in essence, may be more practical and conform to the guidelines [24] that advocate the inclusion of a time-related end point (30, 60, 90 days, etc.). Edwards and colleagues [25] also highlighted that the 30-day mortality outcome in patients undergoing heart valve replacement contributes to approximately 56-57% of deaths observed at 1-year post procedure, based on a series of factors (e.g., sex, age, position of valve lesion, primary or redo surgery and prosthesis type). Thus, 30-day risk prediction models could prove useful in the estimation of survival at 12 months following surgery. Nevertheless, morbidity may now present an increasingly appealing end point in modern cardiac risk models due to increasing survival rates following cardiac surgery across the board. However, such studies may be prone to bias, unless based on cohorts comprising large numbers of homogenous morbidity end points, relative to the size of the study population.
Limitations of the current study may be the relatively limited number of AVR cases in the ASCTS database. However, with over 22 institutions currently contributing to the data set, and the analysis being undertaken after 7 years of collection, one may argue that further delay may result in the lack of a contemporary data set for development. Other limitation of the AVR-Score could extend to its reliability in comparing provider performance across centres. The need for a national benchmark for AVR could perhaps be addressed in future studies, using hierarchical or multilevel models that control for non-random variation in observations within institutions. Nevertheless, the AVR-Score at present could prove a valuable tool for identifying 'high risk' candidates for TAVI and for improving the overall management of severe AS in the elderly and highly morbid patients.
Conclusion
This study confirmed that a locally derived AVR risk prediction model has better calibration in a local AVR cohort. We also found that most predictors identified were consistent with existing literature. The strength of our final model, AVRScore, compared with existing models is the application of the bootstrap method in both variable selection and model validation stages of model development. We anticipate many potential benefits from the use of the AVR-Score as a bedside tool for risk evaluation, including greater awareness amongst clinicians of the preoperative risk factors truly associated with early mortality following AVR in adults and the validation of clinical decisions for surgery versus transcatheter intervention in high-risk patients. 
